SELLAS Life Sciences Group (SLS) Operating Expenses: 2011-2023
Historic Operating Expenses for SELLAS Life Sciences Group (SLS) over the last 4 years, with Dec 2023 value amounting to $8.2 million.
- SELLAS Life Sciences Group's Operating Expenses fell 13.43% to $8.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was $37.9 million, marking a year-over-year decrease of 11.83%. This contributed to the annual value of $37.9 million for FY2023, which is 11.83% down from last year.
- Latest data reveals that SELLAS Life Sciences Group reported Operating Expenses of $8.2 million as of Q4 2023, which was down 12.65% from $9.4 million recorded in Q3 2023.
- SELLAS Life Sciences Group's Operating Expenses' 5-year high stood at $17.7 million during Q1 2022, with a 5-year trough of $4.1 million in Q1 2020.
- In the last 3 years, SELLAS Life Sciences Group's Operating Expenses had a median value of $8.8 million in 2022 and averaged $9.5 million.
- Per our database at Business Quant, SELLAS Life Sciences Group's Operating Expenses surged by 123.22% in 2022 and then plummeted by 36.39% in 2023.
- Quarterly analysis of 4 years shows SELLAS Life Sciences Group's Operating Expenses stood at $6.1 million in 2020, then surged by 91.76% to $11.6 million in 2021, then dropped by 18.70% to $9.4 million in 2022, then decreased by 13.43% to $8.2 million in 2023.
- Its Operating Expenses stands at $8.2 million for Q4 2023, versus $9.4 million for Q3 2023 and $9.1 million for Q2 2023.